Literature DB >> 8394352

Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase by G protein and tyrosine kinase oncoproteins.

A M Gardner1, R R Vaillancourt, G L Johnson.   

Abstract

Mitogen-activated protein kinases (MAPKs) are rapidly phosphorylated and activated in response to a variety of extracellular stimuli in many different cell types. The kinases that activate MAPK, the MAPK/ERK Kinases (MEKs), are also activated by phosphorylation. We have studied the influence of specific oncogenes on the regulation of MEK activity in NIH3T3 and Rat1a fibroblasts. We show that a similar MEK activity phosphorylates and activates MAPK in both growth factor-stimulated (epidermal growth factor and thrombin) and oncogene (gip2, v-src, and v-raf)-transfected cells. Gip2 and v-Src activated MEK-1 in transfected Rat 1a cells, whereas v-Raf activated MEK-1 in transfected NIH3T3 cells. These cell-selective differences in MEK activation parallel constitutive MAPK activation in these cell lines. Stable expression of the v-ras oncogene resulted in little constitutive MEK activation in either cell line, even though both were highly transformed. The growth factor and oncoprotein regulated MEK activity co-fractionated by Mono S chromatography with the 45-kDa MEK-1 protein. We further demonstrate in NIH3T3 and Rat 1a cells that Raf-1 is activated, as measured by its ability to phosphorylate MEK-1, in response to epidermal growth factor but not thrombin. Thus, the regulatory network of protein kinases that activate MAPK converges at MEK but diverges with the kinases that phosphorylate and activate MEK.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394352

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Regulation of myogenesis by fibroblast growth factors requires beta-gamma subunits of pertussis toxin-sensitive G proteins.

Authors:  Y V Fedorov; N C Jones; B B Olwin
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

2.  Selective response of ternary complex factor Sap1a to different mitogen-activated protein kinase subgroups.

Authors:  T Strahl; H Gille; P E Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  Gi2-mediated activation of the MAP kinase cascade.

Authors:  A M Pace; M Faure; H R Bourne
Journal:  Mol Biol Cell       Date:  1995-12       Impact factor: 4.138

4.  Association of MEK1 with p21ras.GMPPNP is dependent on B-Raf.

Authors:  S A Moodie; M J Paris; W Kolch; A Wolfman
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

5.  Inhibition of cell transformation by sulindac sulfide is confined to specific oncogenic pathways.

Authors:  Manish Gala; Ronggai Sun; Vincent W Yang
Journal:  Cancer Lett       Date:  2002-01-10       Impact factor: 8.679

6.  Tumor necrosis factor alpha rapidly activates the mitogen-activated protein kinase (MAPK) cascade in a MAPK kinase kinase-dependent, c-Raf-1-independent fashion in mouse macrophages.

Authors:  B W Winston; C A Lange-Carter; A M Gardner; G L Johnson; D W Riches
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.

Authors:  Jeffrey W Tyner; Heidi Erickson; Michael W N Deininger; Stephanie G Willis; Christopher A Eide; Ross L Levine; Michael C Heinrich; Norbert Gattermann; D Gary Gilliland; Brian J Druker; Marc M Loriaux
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

8.  Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes.

Authors:  R A Franklin; A Tordai; H Patel; A M Gardner; G L Johnson; E W Gelfand
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Mapping of the C5a receptor signal transduction network in human neutrophils.

Authors:  A M Buhl; N Avdi; G S Worthen; G L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.

Authors:  A B Raitano; J R Halpern; T M Hambuch; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.